← Leaderboards
Defu Zeng
City Of Hope/Beckman Research Institute
$13,295,342
Attributed
$13,295,342
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,295,342 · 6
By mechanism
R01$12,349,777 · 4
R56$776,565 · 1
R21$169,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventAllogenicTissuesPathogenesisCellsMediatingPreventionT-LymphocyteInsightHematologic NeoplasmsCd4 Positive T LymphocytesLeadSerumChronic Graft Versus Host DiseaseAnimal ModelAutoreactivityB-LymphocytesRegulatory T-LymphocyteMorbidity - Disease RateAutoantibodiesCurative TreatmentsNovel StrategiesLong-Term SurvivorsDisease Model
Grant awards (29)
Role of autoreactivity in pathogenesis of chronic graft versus host disease$879,263
R01 · FY2025 · HL · contact PI
Pathogenesis, prevention and treatment of corticosteroid-resistant gut GVHD$856,728
R01 · FY2025 · HL · contact PI
Role of autoreactivity in pathogenesis of chronic graft versus host disease$879,263
R01 · FY2024 · HL · contact PI
Pathogenesis, prevention and treatment of corticosteroid-resistant gut GVHD$839,592
R01 · FY2024 · HL · contact PI
Pathogenesis, prevention and treatment of corticosteroid-resistant gut GVHD$856,728
R01 · FY2023 · HL · contact PI
PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activity$388,013
R01 · FY2022 · CA · contact PI
PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activity$395,932
R01 · FY2021 · CA · contact PI
Role of Autoreactivity in pathogenesis of chronic graft versus host disease$342,596
R56 · FY2021 · AI · contact PI
Role of autoreactivity in the pathogenesis of chronic GVHD$425,423
R01 · FY2020 · AI · contact PI
PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activity$395,946
R01 · FY2020 · CA · contact PI
Role of autoreactivity in the pathogenesis of chronic GVHD$425,420
R01 · FY2019 · AI · contact PI
PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activity$392,146
R01 · FY2019 · CA · contact PI
Role of autoreactivity in the pathogenesis of chronic GVHD$425,813
R01 · FY2018 · AI · contact PI
PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activity$404,275
R01 · FY2018 · CA · contact PI
Role of autoreactivity in the pathogenesis of chronic GVHD$433,988
R01 · FY2017 · AI · contact PI
Role of autoreactivity in the pathogenesis of chronic GVHD$144,782
R01 · FY2016 · AI · contact PI
Role of autoreactivity in the pathogenesis of chronic GVHD$433,969
R56 · FY2015 · AI · contact PI
Role of Autoreactivity in Pathogenesis of Chronic GVHD$410,850
R01 · FY2014 · AI · contact PI
Role of Autoreactivity in Pathogenesis of Chronic GVHD$386,199
R01 · FY2013 · AI · contact PI
Role of Autoreactivity in Pathogenesis of Chronic GVHD$410,850
R01 · FY2012 · AI · contact PI
Role of Autoreactivity in Pathogenesis of Chronic GVHD$410,850
R01 · FY2011 · AI · contact PI
Role of Autoreactivity in Pathogenesis of Chronic GVHD$415,000
R01 · FY2010 · AI · contact PI
Role of Autoreactivity in Pathogenesis of Chronic GVHD$410,248
R01 · FY2010 · AI · contact PI
Role of Autoreactivity in Pathogenesis of Chronic GVHD$353,697
R01 · FY2009 · AI · contact PI
Role of Autoreactivity in Pathogenesis of Chronic GVHD$353,697
R01 · FY2008 · AI · contact PI
Role of Autoreactivity in Pathogenesis of Chronic GVHD$360,546
R01 · FY2007 · AI · contact PI
Role of Autoreactivity in Pathogenesis of Chronic GVHD$371,315
R01 · FY2006 · AI · contact PI
Role of Autoreactivity in Pathogenesis of Chronic GVHD$323,213
R01 · FY2005 · AI
Donor CD8+ cell facilitates mixed chimerism in NOD mice$169,000
R21 · FY2005 · DK